Melanoma of the hand and foot: Epidemiological, prognostic and genetic features. A systematic review

British Journal of Dermatology

Volumn 166, Issue 4, 2012, Pages 727-739

  Durbec, F ^a   Martin, L ^b   Derancourt, C ^c   Grange, F ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ANATOMY; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; COCHRANE LIBRARY; DATA BASE; DEVELOPING COUNTRY; ENVIRONMENTAL FACTOR; ETHNIC GROUP; FOOT DISEASE; FOOT SOLE; GENE MUTATION; GENETIC TRAIT; HAND AND FOOT MELANOMA; HAND TUMOR; HEREDITY; HUMAN; MEDLINE; MELANOMA; MOLECULAR GENETICS; NEVUS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SUN EXPOSURE; SYSTEMATIC REVIEW; TOE;

EPIDEMIOLOGIC METHODS; FOOT DISEASES; HAND; HUMANS; MELANOMA; MUTATION; PROGNOSIS; SKIN NEOPLASMS;

EID: 84859118067     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10772.x     Document Type: Review

References (65)

1. Grange F,. Epidemiology of cutaneous melanoma: descriptive data in France and Europe. Ann Dermatol Venereol 2005; 132: 975-82.
2. de Vries E, Bray FI, Coebergh JW, et al. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia. Int J Cancer 2003; 107: 119-26.
3. Albreski D, Sloan SB,. Melanoma of the feet: misdiagnosed and misunderstood. Clin Dermatol 2009; 27: 556-63.
4. Bristow IR, Acland K,. Acral lentiginous melanoma of the foot and ankle: a case series and review of the literature. J Foot Ankle Res 2008; 1: 11.
5. Phan A, Touzet S, Dalle S, et al. Acral lentiginous melanoma: a clinicoprognostic study of 126 cases. Br J Dermatol 2006; 155: 561-9.
6. Nagore E, Pereda C, Botella-Estrada R, et al. Acral lentiginous melanoma presents distinct clinical profile with high cancer susceptibility. Cancer Causes Control 2009; 20: 115-19.
7. Rex J, Paradelo C, Mangas C, et al. Management of primary cutaneous melanoma of the hands and feet: a clinicoprognostic study. Dermatol Surg 2009; 35: 1505-13.
8. Stalkup JR, Orengo IF, Katta R,. Controversies in acral lentiginous melanoma. Dermatol Surg 2002; 28: 1051-9.
9. Reed RJ,. New Concepts in Surgical Pathology of the Skin. New York: John Wiley & Sons, 1976.
10. Beadling C, Jacobson-Dunlop E, Hodi FS, et al. KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res 2008; 14: 6821-8.
11. Tooth L, Ware R, Bain C, et al. Quality of reporting of observational longitudinal research. Am J Epidemiol 2005; 161: 280-8.
12. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61: 344-9.
13. McShane LM, Altman DG, Sauerbrei W, et al. Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 2005; 97: 1180-4.
14. Greenhalgh T,. Assessing the methodological quality of published papers. BMJ 1997; 315: 305-8.
15. Banfield CC, Redburn JC, Dawber RP,. The incidence and prognosis of nail apparatus melanoma. A retrospective study of 105 patients in four English regions. Br J Dermatol 1998; 139: 276-9.
16. Stevens NG, Liff JM, Weiss NS,. Plantar melanoma: is the incidence of melanoma of the sole of the foot really higher in blacks than whites? Int J Cancer 1990; 45: 691-3.
17. Bradford PT, Goldstein AM, McMaster ML, et al. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005. Arch Dermatol 2009; 145: 427-34.
18. Dubrow R, Flannery JT, Liu WL,. Time trends in malignant melanoma of the upper limb in Connecticut. Cancer 1991; 68: 1854-8.
19. Green A, MacLennan R, Youl P, et al. Site distribution of cutaneous melanoma in Queensland. Int J Cancer 1993; 53: 232-6.
20. Bulliard JL, De Weck D, Fisch T, et al. Detailed site distribution of melanoma and sunlight exposure: aetiological patterns from a Swiss series. Ann Oncol 2007; 18: 789-94.
21. Bennett DR, Wasson D, MacArthur JD, et al. The effect of misdiagnosis and delay in diagnosis on clinical outcome in melanomas of the foot. J Am Coll Surg 1994; 179: 279-84.
22. Blessing K, Kernohan NM, Park KG,. Subungual malignant melanoma: clinicopathological features of 100 cases. Histopathology 1991; 19: 425-9.
23. Dwyer PK, MacKie RM, Watt DC, et al. Plantar malignant melanoma in a white Caucasian population. Br J Dermatol 1993; 128: 115-20.
24. Hinds MW,. Anatomic distribution of malignant melanoma of the skin among non-Caucasians in Hawaii. Br J Cancer 1979; 40: 497-9.
25. Krishnamurthy S, Yeole B, Joshi S, et al. The descriptive epidemiology and trends in incidence of nonocular malignant melanoma in Bombay and India. Indian J Cancer 1994; 31: 64-71.
26. Garsaud P, Boisseau-Garsaud AM, Ossondo M, et al. Epidemiology of cutaneous melanoma in the French West Indies (Martinique). Am J Epidemiol 1998; 147: 66-8.
27. Green A, McCredie M, Giles G, et al. Occurrence of melanomas on the upper and lower limbs in Eastern Australia. Melanoma Res 1996; 6: 387-94.
28. Ishihara K, Saida T, Otsuka F, et al. Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update. Int J Clin Oncol 2008; 13: 33-41.
29. Quinn MJ, Wikramanayake R, Thompson JF, McCarthy WH,. Non-subungual melanomas of the hand. J Hand Surg Br 1992; 17: 433-6.
30. Park KG, Blessing K, Kernohan NM,. Surgical aspects of subungual malignant melanomas. The Scottish melanoma group. Ann Surg 1992; 216: 692-5.
31. Green A, McCredie M, MacKie R, et al. A case-control study of melanomas of the soles and palms (Australia and Scotland). Cancer Causes Control 1999; 10: 21-5.
32. Rolon PA, Kramarova E, Rolon HI, et al. Plantar melanoma: a case-control study in Paraguay. Cancer Causes Control 1997; 8: 850-6.
33. Hsueh EC, Lucci A, Qi K, Morton DL,. Survival of patients with melanoma of the lower extremity decreases with distance from the trunk. Cancer 1999; 85: 383-8.
34. Nagore E, Oliver V, Botella-Estrada R, et al. Pronostic factors in localized invasive cutaneous melanoma: high value of mitotic rate, vascular invasion and microscopic satellitosis. Melanoma Res 2005; 15: 169-77.
35. Barnes BC, Seigler HF, Saxby TS, et al. Melanoma of the foot. J Bone Joint Surg Am 1994; 76: 892-8.
36. Kuno Y, Ishihara K, Yamazaki N, et al. Clinical and pathological features of cutaneous malignant melanoma: a retrospective analysis of 124 Japanese patients. Jpn J Clin Oncol 1996; 26: 144-51.
37. Soudry E, Gutman H, Feinmesser M, et al. 'Gloves-and-socks' melanoma: does histology make a difference? Dermatol Surg 2008; 34: 1372-8.
38. Moehrle M, Metzger S, Schippert W, et al. 'Functional' surgery in subungual melanoma. Dermatol Surg 2003; 29: 366-74.
39. Bormann G, Marsch WC, Haerting J, et al. Concomitant traumas influence prognosis in melanomas of the nail apparatus. Br J Dermatol 2006; 155: 76-80.
40. Slingluff CL Jr, Vollmer R, Seigler HF,. Acral melanoma: a review of 185 patients with identification of prognostic variables. J Surg Oncol 1990; 45: 91-8.
41. Heaton KM, El-Naggar A, Ensign LG, et al. Surgical management and prognostic factors in patients with subungual melanoma. Ann Surg 1994; 219: 197-204.
42. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005; 353: 2135-47.
43. Ashida A, Takata M, Murata H, et al. Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas. Int J Cancer 2009; 124: 863-8.
44. Curtin JA, Busam K, Pinkel D, et al. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 2006; 24: 4340-6.
45. Maldonado JL, Fridlyand J, Patel H, et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 2003; 95: 1878-80.
46. Glatz-Krieger K, Pache M, Tapia C, et al. Anatomic site-specific patterns of gene copy number gains in skin, mucosal, and uveal melanomas detected by fluorescence in situ hybridization. Virchows Arch 2006; 449: 328-33.
47. Takata M, Goto Y, Ichii N, et al. Constitutive activation of the mitogen-activated protein kinase signaling pathway in acral melanomas. J Invest Dermatol 2005; 125: 318-22.
48. Saldanha G, Potter L, DaForno P, et al. Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies. Clin Cancer Res 2006; 12: 4499-505.
49. Torres-Cabala CA, Wang WL, Trent J, et al. Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type. Mod Pathol 2009; 22: 1446-56.
50. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer, 2010. Available at: http://globocan.iarc.fr (last accessed 13 January 2012).
51. O'Donnell JM, Nácul FE, (eds). Surgical Intensive Care Medicine, 2nd edn. New York, NY: Springer, 2010.
52. Green A,. A theory of site distribution of melanomas: Queensland, Australia. Cancer Causes Control 1992; 3: 513-16.
53. Feibleman CE, Stoll H, Maize JC,. Melanomas of the palm, sole, and nailbed: a clinicopathologic study. Cancer 1980; 46: 2492-504.
54. Ghariani N, Boussofara L, Kenani N, et al. Post traumatic amelanotic subungual melanoma. Dermatol Online J 2008; 14: 13.
55. Hwang K, Han JY, Lee SI,. Multiple malignant melanomas at different burn scar areas: a case report. Dermatol Surg 2004; 30: 562-5.
56. Atzeni M, Serratore F, Zaccheddu F, et al. Multiple melanoma arising on a burn scar and extensive sunburn: a case report and a review of the literature. Melanoma Res 2009; 19: 195-8.
57. Roberts AH,. Subungual melanoma following a single injury. J Hand Surg Br 1984; 9: 328-30.
58. el Baba F, Blumenkranz M,. Malignant melanoma at the site of penetrating ocular trauma. Arch Ophthalmol 1986; 104: 405-9.
59. Stevens A, Spooner D,. Malignant melanoma occurring within a previously irradiated area. Clin Oncol (R Coll Radiol) 1999; 11: 426-8.
60. Dal'Forno T, Cartell A, Bakos L,. Dermabrasion in acquired melanocytic nevi: a histopathological and immunohistochemical study. Am J Dermatopathol 2011; 33: 40-6.
61. Phan A, Touzet S, Dalle S, et al. Acral lentiginous melanoma: histopathological prognostic features of 121 cases. Br J Dermatol 2007; 157: 311-18.
62. Gogas H, Eggermont AM, Hauschild A, et al. Biomarkers in melanoma. Ann Oncol 2009; 20 (Suppl. 6): vi8-13.
63. Garrido MC, Bastian BC,. KIT as a therapeutic target in melanoma. J Invest Dermatol 2010; 130: 20-7.
64. Flaherty KT, Puzanov I, Kim KB, et al. Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 2010; 363: 809-19.
65. Puzanov I, Flaherty KT,. Targeted molecular therapy in melanoma. Semin Cutan Med Surg 2010; 29: 196-201.